| scholarly article | Q13442814 |
| P50 | author | Mariapia A Degli-Esposti | Q90038426 |
| Mark J. Smyth | Q38544864 | ||
| P2093 | author name string | Serani L H van Dommelen | |
| Hyacinth A Tabarias | |||
| P2860 | cites work | Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells | Q59387569 |
| Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide | Q60489559 | ||
| NKT cells and tumor immunity—a double-edged sword | Q62230473 | ||
| Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide | Q63363334 | ||
| The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice | Q63363340 | ||
| The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes | Q63363354 | ||
| Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection | Q71718210 | ||
| Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells | Q73098737 | ||
| alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells | Q73449902 | ||
| Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 | ||
| Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice | Q73977788 | ||
| Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes | Q74455329 | ||
| Perforin is a major contributor to NK cell control of tumor metastasis | Q77823551 | ||
| Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production | Q77879159 | ||
| A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system | Q77929123 | ||
| Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype | Q78145090 | ||
| Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide | Q78145103 | ||
| CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 | ||
| Biology of natural killer cells | Q29619728 | ||
| NKT cells: facts, functions and fallacies. | Q34091324 | ||
| NK cells and NKT cells in innate defense against viral infections | Q34332682 | ||
| NKT cells - conductors of tumor immunity? | Q34547180 | ||
| NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus | Q34999264 | ||
| Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. | Q35874845 | ||
| Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells | Q36096376 | ||
| Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. | Q36363051 | ||
| Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration | Q36365733 | ||
| Natural killer T cell activation inhibits hepatitis B virus replication in vivo. | Q36368956 | ||
| CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution | Q36404242 | ||
| CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity | Q36919192 | ||
| alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria | Q37229005 | ||
| Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells | Q40781889 | ||
| IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk | Q40822179 | ||
| Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. | Q41005207 | ||
| Activation and function of natural killer cell responses during viral infections | Q41353152 | ||
| Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 | ||
| Role of NK cells in tumour growth and metastasis in beige mice | Q41643296 | ||
| The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells | Q41815553 | ||
| NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. | Q43562662 | ||
| Control of infections by NK cells. | Q43903095 | ||
| Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. | Q45734984 | ||
| CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus | Q45737315 | ||
| Genetic control of murine cytomegalovirus infection: Virus titres in resistant and susceptible strains of mice | Q45796241 | ||
| Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. | Q52176215 | ||
| Vital involvement of a natural killer cell activation receptor in resistance to viral infection. | Q54010687 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytomegaloviral disease | Q2076966 |
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | 1877-1884 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells | |
| P478 | volume | 77 |
| Q35235639 | A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection |
| Q42727113 | A seek-and-hide game between Cd1-restricted T cells and herpesviruses |
| Q36403849 | A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan |
| Q41385090 | Activated NKT cells imprint NK-cell differentiation, functionality and education |
| Q34287659 | Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection |
| Q27318814 | Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis |
| Q41639759 | Adjuvant effects of therapeutic glycolipids administered to a cohort of NKT cell-diverse pigs |
| Q36300011 | An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity |
| Q38896926 | Analysis of invariant natural killer T cells in human paracoccidioidomycosis. |
| Q37499317 | Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity |
| Q64103603 | CCR2+ migratory macrophages with M1 status are the early-responders in the cornea of HSV-1 infected mice |
| Q52332737 | CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil". |
| Q35778127 | CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections |
| Q83859666 | CD1d expression on hemopoietic cells promotes CD4+ Th1 response in coxsackievirus B3 induced myocarditis |
| Q41494923 | CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. |
| Q26796132 | CD1d- and MR1-Restricted T Cells in Sepsis |
| Q47249337 | Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study |
| Q37003800 | Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals |
| Q33965560 | Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infections |
| Q33782527 | Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7 |
| Q41858795 | Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo. |
| Q37693968 | Distinct requirements for activation of NKT and NK cells during viral infection |
| Q35798141 | Genetic control of NKT cell numbers |
| Q42850482 | Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function |
| Q44757727 | Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling |
| Q57160792 | Herpes simplex virus-1 specifically targets human CD1d antigen presentation to enhance its pathogenicity |
| Q36395876 | Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation |
| Q37462515 | Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity |
| Q45372912 | IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells |
| Q47604842 | ILC1 Confer Early Host Protection at Initial Sites of Viral Infection |
| Q35259980 | Identification of Mouse Cytomegalovirus Resistance Loci by ENU Mutagenesis |
| Q59348948 | Immune evasion of the CD1d/NKT cell axis |
| Q33835386 | Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn |
| Q40334364 | Impaired NK cell cytotoxicity by high level of interferon-gamma in concanavalin A-induced hepatitis |
| Q43251023 | Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice |
| Q34151144 | In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models |
| Q40011111 | Inhibition of CD1 antigen presentation by human cytomegalovirus |
| Q60146885 | Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction |
| Q43626158 | Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. |
| Q37822744 | Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens |
| Q36799695 | Invariant NKT cells and tolerance |
| Q28511526 | Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans |
| Q37211135 | Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis |
| Q33204301 | Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1.1+ cells |
| Q91198621 | Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells |
| Q84115618 | Kinetics of ocular and systemic antigen-specific T-cell responses elicited during murine cytomegalovirus retinitis |
| Q43996244 | Long-term loss of canonical NKT cells following an acute virus infection |
| Q33686132 | Ly49C-dependent control of MCMV Infection by NK cells is cis-regulated by MHC Class I molecules |
| Q46414672 | NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection |
| Q33352690 | NK cell-like behavior of Valpha14i NK T cells during MCMV infection |
| Q30433546 | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection |
| Q35662327 | NK-, NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia |
| Q57831257 | NKT cell immune responses to viral infection |
| Q35798179 | NKT cells and viral immunity |
| Q37615203 | NKT cells: friend or foe during viral infections? |
| Q27319958 | Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus |
| Q34605137 | Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. |
| Q36652221 | Natural killer cells in viral infection: more than just killers. |
| Q40726486 | Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver |
| Q39833305 | Potentiation of murine innate immunity by alpha-galacturonosyl-type glycosphingolipids isolated from Sphingomonas yanoikuyae and S. terrae |
| Q30311185 | Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. |
| Q45550503 | Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. |
| Q45399805 | Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease |
| Q40659279 | Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell |
| Q24294851 | Role of CD1d-restricted NKT cells in microbial immunity |
| Q36879807 | Role of NKT cells in the digestive system. I. Invariant NKT cells and liver diseases: is there strength in numbers? |
| Q37874633 | Targeting the diverse immunological functions expressed by hepatic NKT cells |
| Q36594211 | The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon |
| Q24648939 | The role of NKT cells in tumor immunity |
| Q37122052 | The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock |
| Q60489405 | The roles of interferon-γ and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity |
| Q36472036 | The surprising diversity of lipid antigens for CD1-restricted T cells |
| Q36814724 | The unique role of natural killer T cells in the response to microorganisms |
| Q63246320 | Tissue-Resident Innate and Innate-Like Lymphocyte Responses to Viral Infection |
| Q26825059 | Turned on by danger: activation of CD1d-restricted invariant natural killer T cells |
| Q36354705 | V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes |
| Q36299933 | Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients |
| Q40015983 | Viral danger signals control CD1d de novo synthesis and NKT cell activation |
| Q38809547 | What rheumatologists need to know about innate lymphocytes |
| Q26800120 | iNKT Cells and Their Potential Lipid Ligands during Viral Infection |
Search more.